{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:40:37Z","timestamp":1793302837460,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T00:00:00Z","timestamp":1653177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.biopha.2022.113188","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T16:36:53Z","timestamp":1653669413000},"page":"113188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"151","author":[{"given":"Xia","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113188_bib1","first-page":"1134","article-title":"Uber einen eigenartigen schweren Erkrankungsprozess der Hirninde","volume":"25","author":"Alzheimer","year":"1906","journal-title":"Neurol. Cent."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-3639.1991.tb00666.x","article-title":"Alzheimer\u2019s disease: a description of the structural lesions","volume":"1","author":"Probst","year":"1991","journal-title":"Brain Pathol."},{"issue":"s1","key":"10.1016\/j.biopha.2022.113188_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-191280","article-title":"Current status of healthy aging and dementia research: a symposium summary","volume":"72","author":"Reddy","year":"2019","journal-title":"J. Alzheimer\u2019s. Dis.: JAD"},{"issue":"6005","key":"10.1016\/j.biopha.2022.113188_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113188_bib5","article-title":"The state of the art of dementia research: new frontiers","volume":"2018","author":"Patterson","year":"2018","journal-title":"World Alzheimer Rep."},{"key":"10.1016\/j.biopha.2022.113188_bib6","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer\u2019s disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Research"},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/fn.2013.34190","article-title":"Molecular mechanisms of neuropathological changes in Alzheimer\u2019s disease: a review","volume":"51","author":"\u0160er\u00fd","year":"2013","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.biopha.2022.113188_bib9","unstructured":"A. Jap, P.H.R.a.b.c.d. e, Defective mitophagy in Alzheimer's disease, Ageing Research Reviews 64."},{"issue":"11","key":"10.1016\/j.biopha.2022.113188_bib10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/13543784.2019.1683160","article-title":"Investigational BACE inhibitors for the treatment of Alzheimer\u2019s disease","volume":"28","author":"Imbimbo","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"87(1)","key":"10.1016\/j.biopha.2022.113188_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/prd.12389","article-title":"Alzheimer disease and the periodontal patient: new insights, connections, and therapies","volume":"2000","author":"Ryder","year":"2021","journal-title":"Periodontology"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer\u2019s disease","volume":"24","author":"Hung","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cpdd.689","article-title":"Assessment of Azeliragon QTc Liability Through Integrated, Model\u2010Based Concentration QTc Analysis","volume":"8","author":"Burstein","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.14283\/jpad.2018.18","article-title":"Development of Azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer\u2019s disease","volume":"5","author":"Burstein","year":"2018","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"issue":"8","key":"10.1016\/j.biopha.2022.113188_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1177\/0963689719853540","article-title":"Protective effect of hyperbaric oxygen therapy on cognitive function in patients with vascular dementia","volume":"28","author":"Xu","year":"2019","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"New Engl. J. Med."},{"issue":"7618","key":"10.1016\/j.biopha.2022.113188_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3233\/JAD-150376","article-title":"Two phase 2 multiple ascending\u2013dose studies of vanutide cridificar (ACC-001) and QS-21 adjuvant in mild-to-moderate Alzheimer\u2019s disease","volume":"51","author":"Pasquier","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"7651","key":"10.1016\/j.biopha.2022.113188_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature22067","article-title":"Human umbilical cord plasma proteins revitalize hippocampal function in aged mice","volume":"544","author":"Castellano","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamaneurol.2018.3288","article-title":"Safety, tolerability, and feasibility of young plasma infusion in the plasma for Alzheimer symptom amelioration study: a randomized clinical trial","volume":"76","author":"Sharon","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biopha.2022.113188_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2022.113188_bib22","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2147\/CIA.S159920","article-title":"Clinical efficacy and safety of donepezil in the treatment of Alzheimer\u2019s disease in Chinese patients","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/104012371803000307","article-title":"The use of memantine in neuropsychiatric disorders: an overview","volume":"30","author":"Lu","year":"2018","journal-title":"Ann. Clin. Psychiatry.: Off. J. Am. Acad. Clin. Psychiatr."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(19)30480-6","article-title":"A resurrection of aducanumab for Alzheimer\u2019s disease","volume":"19","author":"Schneider","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj20021637","article-title":"Positive and negative regulation of T-cell activation through kinases and phosphatases","volume":"371","author":"Mustelin","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(94)01039-0","article-title":"Phorbol 12\u2013myristate 13\u2013acetic acid inhibits PTP1B activity in human mesangial cells A possible mechanism of enhanced tyrosine phosphorylation","volume":"353","author":"Kiyomoto","year":"1994","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc2980","article-title":"Inside the human cancer tyrosine phosphatome","volume":"11","author":"Julien","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6209","article-title":"Structural basis for extracellular cis and trans RPTP\u03c3 signal competition in synaptogenesis","volume":"5","author":"Coles","year":"2014","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2022.113188_bib29","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1073\/pnas.1222164110","article-title":"Shp2 plays a crucial role in cell structural orientation and force polarity in response to matrix rigidity","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6964","key":"10.1016\/j.biopha.2022.113188_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature02093","article-title":"Eyes absent represents a class of protein tyrosine phosphatases","volume":"426","author":"Rayapureddi","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12539-009-0047-4","article-title":"Structural flexibility and interactions of PTP1B\u2019s S-loop","volume":"1","author":"Wang","year":"2009","journal-title":"Interdiscip. Sci.: Comput. Life Sci."},{"key":"10.1016\/j.biopha.2022.113188_bib32","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4014\/jmb.1701.01079","article-title":"Structure-based virtual screening of protein tyrosine phosphatase inhibitors: significance, challenges, and solutions","volume":"27","author":"Reddy","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113188_bib33","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.cellsig.2014.08.014","article-title":"Effects of protein tyrosine phosphatase-PEST are reversed by Akt in T cells","volume":"26","author":"Arimura","year":"2014","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/JOE-14-0178","article-title":"Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6\/Shp1 in zebrafish","volume":"222","author":"Marin-Juez","year":"2014","journal-title":"J. Endocrinol."},{"issue":"30","key":"10.1016\/j.biopha.2022.113188_bib35","doi-asserted-by":"crossref","first-page":"47927","DOI":"10.18632\/oncotarget.10066","article-title":"The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy","volume":"7","author":"Storr","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib36","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/MCB.02462-05","article-title":"Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response","volume":"27","author":"Hall\u00e9","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib37","first-page":"133","article-title":"Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools","volume":"11","author":"Craig","year":"2011","journal-title":"Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem. -Anti-Cancer Agents)"},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/apha.12515","article-title":"Biological and physiological role of reactive oxygen species\u2013the good, the bad and the ugly","volume":"214","author":"Zuo","year":"2015","journal-title":"Acta Physiol."},{"issue":"19","key":"10.1016\/j.biopha.2022.113188_bib39","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1111\/febs.13378","article-title":"Mapping the SUMO ylated landscape","volume":"282","author":"Eifler","year":"2015","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.biopha.2022.113188_bib40","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-05-3116","article-title":"PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility","volume":"66","author":"Fiordalisi","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1097-2765(02)00445-8","article-title":"Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo","volume":"9","author":"Meng","year":"2002","journal-title":"Mol. Cell"},{"issue":"25","key":"10.1016\/j.biopha.2022.113188_bib42","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1074\/jbc.273.25.15366","article-title":"Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor","volume":"273","author":"Lee","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5234","key":"10.1016\/j.biopha.2022.113188_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.270.5234.296","article-title":"Requirement for generation of H2O2 for platelet-derived growth factor signal transduction","volume":"270","author":"Sundaresan","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1742-4658.2012.08655.x","article-title":"Protein tyrosine phosphatase structure\u2013function relationships in regulation and pathogenesis","volume":"280","author":"B\u00f6hmer","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2022.113188_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112117","article-title":"Therapeutic potential of targeting SHP2 in human developmental disorders and cancers","volume":"190","author":"Shen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0014-5793(03)00603-3","article-title":"PTP1B: from the sidelines to the front lines!","volume":"546","author":"Tonks","year":"2003","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.biopha.2022.113188_bib47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrm2039","article-title":"Protein tyrosine phosphatases: from genes, to function, to disease","volume":"7","author":"Tonks","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"19","key":"10.1016\/j.biopha.2022.113188_bib48","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1111\/febs.13378","article-title":"Mapping the SUMOylated landscape","volume":"282","author":"Eifler","year":"2015","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncb1522","article-title":"Regulation of protein tyrosine phosphatase 1B by sumoylation","volume":"9","author":"Dadke","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ymeth.2013.09.012","article-title":"Analysis of PTP1B sumoylation","volume":"65","author":"Saha","year":"2014","journal-title":"Methods"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113188_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbapap.2005.09.005","article-title":"Functional studies of protein tyrosine phosphatases with chemical approaches","volume":"1754","author":"Zhang","year":"2005","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/smim.2000.0209","article-title":"Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases","volume":"12","author":"Li","year":"2000","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.104.005421","article-title":"Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2","volume":"68","author":"Haider","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib54","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cellsig.2011.10.001","article-title":"Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver","volume":"24","author":"D\u00edaz","year":"2012","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.biopha.2022.113188_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101152","article-title":"PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor","volume":"14","author":"Koga","year":"2021","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113188_bib56","first-page":"1","article-title":"LMWPTP modulates the antioxidant response and autophagy process in human chronic myeloid leukemia cells","volume":"466","author":"Faria","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-3639.1991.tb00666.x","article-title":"Alzheimer\u2019s disease: a description of the structural lesions","volume":"1","author":"Alphonse","year":"1991","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib58","first-page":"8","article-title":"Tian, Protein phosphatase 2A, a key player in Alzheimer\u2019s disease","volume":"3","author":"Liu","year":"2009","journal-title":"\u533b\u5b66\u524d\u6cbf"},{"key":"10.1016\/j.biopha.2022.113188_bib59","doi-asserted-by":"crossref","unstructured":"Kim, Yohan, Tau associates with protein tyrosine phosphatase SHP2, 2017.","DOI":"10.1016\/j.jalz.2017.06.852"},{"key":"10.1016\/j.biopha.2022.113188_bib60","doi-asserted-by":"crossref","unstructured":"T. Kanno, A. Tsuchiya, A. Tanaka, T. Nishizaki, Combination of PKC\u03b5 Activation and PTP1B Inhibition Effectively Suppresses A\u03b2-Induced GSK-3\u03b2 Activation and Tau Phosphorylation, Molecular Neurobiology, 2015.","DOI":"10.1007\/s12035-015-9405-x"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/14728222.2013.843670","article-title":"New insights into the role of glycogen synthase kinase-3 in Alzheimer\u2019s disease","volume":"18","author":"Medina","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"14","key":"10.1016\/j.biopha.2022.113188_bib62","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.229054","article-title":"Tau interacts with SHP2 in neuronal systems and in Alzheimer\u2019s disease brains","volume":"132","author":"Kim","year":"2019","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.biopha.2022.113188_bib63","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2120-19.2019","article-title":"Neuronal protein tyrosine phosphatase 1B hastens amyloid \u03b2-associated Alzheimer\u2019s disease in mice","volume":"40","author":"Ricke","year":"2020","journal-title":"J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2022.113188_bib64","article-title":"Dual-specificity phosphatases in mental and neurological disorders","volume":"198","author":"An","year":"2020","journal-title":"Prog. Neurobiol."},{"issue":"48","key":"10.1016\/j.biopha.2022.113188_bib65","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1038\/sj.onc.1208158","article-title":"Src in synaptic transmission and plasticity","volume":"23","author":"Kalia","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12104-009-9145-9","article-title":"Sequence-specific 1HN, 13C and 15N backbone resonance assignments of the 34 kDa Paramecium bursaria Chlorella virus 1 (PBCV1) DNA ligase","volume":"3","author":"Piserchio","year":"2009","journal-title":"Biomol. Nmr Assign."},{"key":"10.1016\/j.biopha.2022.113188_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/BJ20051931","article-title":"Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases","volume":"395","author":"Eswaran","year":"2006","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.biopha.2022.113188_bib68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tips.2006.08.005","article-title":"MAPK-specific tyrosine phosphatases: new targets for drug discovery?","volume":"27","author":"Barr","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib69","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cell.2008.11.038","article-title":"Large-scale structural analysis of the classical human protein tyrosine phosphatome","volume":"136","author":"Barr","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113188_bib70","unstructured":"H. Fang, Structure, Function and Modulation of Striatal-enriched Protein Tyrosine Phosphatase (STEP), Current Medicinal Chemistry, 2021."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib71","first-page":"303","article-title":"Striatal-enriched protein tyrosine phosphatase in Alzheimer\u2019s Disease","volume":"64","author":"Jian","year":"2012","journal-title":"Adv. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113188_bib72","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4155\/fmc.10.241","article-title":"Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development","volume":"2","author":"Barr","year":"2010","journal-title":"Fut. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113188_bib73","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1742-4658.2008.06251.x","article-title":"Protein tyrosine phosphatases: structure-function relationships","volume":"275","author":"Tabernero","year":"2008","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib74","article-title":"Brain somatic mutations observed in Alzheimer's disease associated with aging and dysregulation of tau phosphorylation, Nature","volume":"10","author":"Park","year":"2019","journal-title":"Communications"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-020-00560-w","article-title":"Dopamine response gene pathways in dorsal striatum MSNs from a gene expression viewpoint: cAMP-mediated gene networks","volume":"21","author":"Babenko","year":"2020","journal-title":"BMC Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113188_bib76","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1007\/s12035-015-9335-7","article-title":"BDNF induces striatal-enriched protein tyrosine phosphatase 61 degradation through the proteasome","volume":"53","author":"Saavedra","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"11\u201312","key":"10.1016\/j.biopha.2022.113188_bib77","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.mad.2011.09.005","article-title":"Short bouts of mild-intensity physical exercise improve spatial learning and memory in aging rats: Involvement of hippocampal plasticity via AKT, CREB and BDNF signaling","volume":"132","author":"Aguiar","year":"2011","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib78","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib79","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"issue":"42","key":"10.1016\/j.biopha.2022.113188_bib80","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1523\/JNEUROSCI.2666-08.2008","article-title":"The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation","volume":"28","author":"Zhang","year":"2008","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2022.113188_bib81","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1111\/j.1460-9568.2006.04837.x","article-title":"Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP)","volume":"23","author":"Braithwaite","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113188_bib82","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.cr.7290055","article-title":"The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions","volume":"10","author":"Cheng","year":"2000","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2022.113188_bib84","unstructured":"S.G. Julien, N. Dub\u00e9, S. Hardy, M.L. Tremblay, Inside the human cancer tyrosine phosphatome, Nature Reviews Cancer."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib85","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal Structure of the Tyrosine Phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.biopha.2022.113188_bib86","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1349-7006.2009.01257.x","article-title":"Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation","volume":"100","author":"Matozaki","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2022.113188_bib87","doi-asserted-by":"crossref","unstructured":"M., Scott, Latanya, R., Lawrence, Harshani, M., Sebti, Said, J., Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery, CPD, 2010.","DOI":"10.2174\/138161210791209027"},{"issue":"10","key":"10.1016\/j.biopha.2022.113188_bib88","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejmg.2015.08.005","article-title":"SHP2 sails from physiology to pathology","volume":"58","year":"2015","journal-title":"Eur. J. Med. Genet."},{"issue":"9","key":"10.1016\/j.biopha.2022.113188_bib89","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","article-title":"Phosphorylation of Tau by Fyn: implications for Alzheimer\u2019s disease","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2022.113188_bib90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2017.01.030","article-title":"GAB2 rs2373115 variant contributes to Alzheimer\u2019s disease risk specifically in European population","volume":"375","author":"Hu","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2022.113188_bib91","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE e4 carriers","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2022.113188_bib92","doi-asserted-by":"crossref","unstructured":"A.J. Barr, J. Debreczeni, J. Eswaran, S. Knapp, Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-\u00c5 resolution, Proteins: Structure, Function, and Bioinformatics, 2006.","DOI":"10.2210\/pdb2bzl\/pdb"},{"issue":"12","key":"10.1016\/j.biopha.2022.113188_bib93","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nsb1295-1043","article-title":"Protein tyrosine phosphatases take off","volume":"2","author":"Barford","year":"1995","journal-title":"Nat. Struct. Biol."},{"issue":"29","key":"10.1016\/j.biopha.2022.113188_bib94","doi-asserted-by":"crossref","first-page":"19688","DOI":"10.1016\/S0021-9258(18)55047-X","article-title":"Cloning, bacterial expression, purification, and characterization of the cytoplasmic domain of rat LAR, a receptor-like protein tyrosine phosphatase","volume":"266","author":"Pot","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.biopha.2022.113188_bib95","doi-asserted-by":"crossref","first-page":"20189","DOI":"10.1016\/S0021-9258(17)32144-0","article-title":"Brain-specific receptor-type protein-tyrosine phosphatase RPTP beta is a chondroitin sulfate proteoglycan in vivo","volume":"269","author":"Shitara","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib96","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cellsig.2007.10.002","article-title":"The molecular functions of Shp2 in the Ras\/Mitogen-activated protein kinase (ERK1\/2) pathway","volume":"20","author":"Dance","year":"2008","journal-title":"Cell. Signal."},{"issue":"7036","key":"10.1016\/j.biopha.2022.113188_bib97","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nature03469","article-title":"Visualizing the mechanical activation of Src","volume":"434","author":"Wang","year":"2005","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.biopha.2022.113188_bib98","doi-asserted-by":"crossref","first-page":"26029","DOI":"10.1074\/jbc.270.44.26029","article-title":"A single point mutation switches the specificity of group III Src homology (SH) 2 domains to that of group I SH2 domains. J Biol Chem 270: 26029\u221226032","volume":"270","author":"Songyang","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.biopha.2022.113188_bib99","doi-asserted-by":"crossref","first-page":"18201","DOI":"10.1074\/jbc.M910273199","article-title":"Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and alpha","volume":"275","author":"Peters","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib100","article-title":"Flavonoids from Sophora alopecuroides L. improve palmitate-induced insulin resistance by inhibiting PTP1B activity in vitro","volume":"35","author":"Zhang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/fn.2013.34190","article-title":"Molecular mechanisms of neuropathological changes in Alzheimer\u2019s disease: a review","volume":"51","author":"Ser\u00fd","year":"2013","journal-title":"Folia Neuropathol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113188_bib102","first-page":"1121","article-title":"The role of cerebral amyloid accumulation in common forms of Alzheimer disease","volume":"115","author":"Gandy","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.biopha.2022.113188_bib103","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1007\/s12035-015-9405-x","article-title":"Combination of PKC\u03b5 activation and PTP1B INhibition Effectively Suppresses A\u03b2-Induced GSK-3\u03b2 activation and tau phosphorylation","volume":"53","author":"Kanno","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2022.113188_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N|[ndash]|terminus of |[beta]||[ndash]|amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2022.113188_bib105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnagi.2017.00007","article-title":"Protein tyrosine phosphatase 1B (PTP1B): a potential target for Alzheimer\u2019s therapy","volume":"9","author":"Vieira","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2022.113188_bib106","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1742-4658.2012.08716.x","article-title":"Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling","volume":"280","author":"Caunt","year":"2013","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/onc.2009.300","article-title":"Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein","volume":"29","author":"Abedini","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib108","first-page":"421","article-title":"The family-wide structure and function of human dual-specificity protein phosphatases","volume":"70","author":"Jeong","year":"2014","journal-title":"Acta Crystallogr."},{"issue":"21","key":"10.1016\/j.biopha.2022.113188_bib109","article-title":"Structural and evolutionary relationships among protein tyrosine phosphatase domains","volume":"21","author":"N","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/187152011794941190","article-title":"Dual-specificity MAP kinase phosphatases as targets of cancer treatment","volume":"11","author":"Nunes-Xavier","year":"2011","journal-title":"Anticancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib111","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cell.2008.11.038","article-title":"Large-scale structural analysis of the classical human protein tyrosine phosphatome","volume":"136","author":"Barr","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib112","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/prot.21224","article-title":"Crystal structure of the catalytic domain of human DUSP5, a dual specificity MAP kinase protein phosphatase","volume":"66","author":"Jeong","year":"2007","journal-title":"Proteins"},{"issue":"5266","key":"10.1016\/j.biopha.2022.113188_bib113","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.272.5266.1328","article-title":"Crystal structure of the dual specificity protein phosphatase VHR","volume":"272","author":"Yuvaniyama","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib114","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/5861","article-title":"Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation","volume":"6","author":"Stewart","year":"1999","journal-title":"Nat. Struct. Biol."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2022.113188_bib115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1107\/S1399004713029866","article-title":"The family-wide structure and function of human dual-specificity protein phosphatases","volume":"70","author":"Jeong","year":"2014","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"issue":"5","key":"10.1016\/j.biopha.2022.113188_bib116","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cell.2005.05.016","article-title":"Redox redux: revisiting PTPs and the control of cell signaling","volume":"121","author":"Tonks","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113188_bib117","doi-asserted-by":"crossref","unstructured":"W.D. GE, Free Radicals in the Physiological Control of Cell Function, Physiological Reviews 82, 2002.","DOI":"10.1152\/physrev.00018.2001"},{"key":"10.1016\/j.biopha.2022.113188_bib118","unstructured":"Y. Du, Y. Du, Y. Zhang, Z. Huang, M. Fu, J. Li, Y. Pang, P. Lei, Y.T. Wang, W. Song, MKP-1 reduces A\u03b2 generation and alleviates cognitive impairments in Alzheimer's disease models, Signal Transduction and Targeted Therapy."},{"issue":"5","key":"10.1016\/j.biopha.2022.113188_bib119","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jnc.13597","article-title":"Dual-specificity phosphatase 26 (DUSP26) stimulates A beta 42 generation by promoting amyloid precursor protein axonal transport during hypoxia","volume":"137","author":"Jung","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","article-title":"Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer\u2019s disease pathology","volume":"93","author":"Griffin","year":"2010","journal-title":"J. Neurochem."},{"issue":"13","key":"10.1016\/j.biopha.2022.113188_bib121","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.febslet.2006.04.064","article-title":"PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3","volume":"580","author":"Kerr","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2022.113188_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/nn.4225","article-title":"PTEN recruitment controls synaptic and cognitive function in Alzheimer\u2019s models","author":"Knafo","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib123","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/diseases6020028","article-title":"Implications of PI3K\/AKT\/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease","volume":"6","author":"Satoru","year":"2018","journal-title":"Diseases"},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib124","first-page":"132","article-title":"PTEN: a molecular target for neurodegenerative disorders, translational","volume":"3","author":"Ismail","year":"2012","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.biopha.2022.113188_bib125","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1248\/bpb.22.794","article-title":"Abundance of low molecular weight phosphotyrosine protein phosphatase in the nerve-ending fraction in the brain","volume":"22","author":"Tanino","year":"1999","journal-title":"Biol. Pharm. Bull."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2022.113188_bib126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(04)00112-7","article-title":"Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling","volume":"560","author":"Cho","year":"2004","journal-title":"Febs Lett."},{"key":"10.1016\/j.biopha.2022.113188_bib127","article-title":"Journal pre-proof synaptic basis of Alzheimer\u2019s Disease: focus on synaptic amyloid beta, P-Tau and mitochondria","volume":"65","author":"John","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2022.113188_bib128","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0002-9440(10)64837-7","article-title":"The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer\u2019s disease","volume":"157","author":"Ding","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113188_bib129","first-page":"S407","article-title":"The mTOR pathway in Alzheimer\u2019s disease","volume":"7","author":"Nagy","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"issue":"2","key":"10.1016\/j.biopha.2022.113188_bib130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1471-4159.2002.01143.x","article-title":"Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis","volume":"83","author":"Delobel","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2022.113188_bib131","article-title":"The Eya phosphatase: its unique role in cancer","author":"Zhou","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib132","doi-asserted-by":"crossref","DOI":"10.18632\/aging.202272","article-title":"PTP1B inhibitor alleviates deleterious microglial activation and neuronal injury after ischemic stroke by modulating the ER stress-autophagy axis via PERK signaling in microglia","volume":"12","author":"Zhu","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.biopha.2022.113188_bib133","article-title":"Direct activation of protein phosphatase 2A (PP2A) by tricyclic sulfonamides ameliorates Alzheimer\u2019s disease pathogenesis in cell and animal models","volume":"3","author":"Wei","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"366\u2013381","key":"10.1016\/j.biopha.2022.113188_bib134","article-title":"FTY720 in CNS injuries: molecular mechanisms and therapeutic potential","volume":"164","author":"Zhang","year":"2020","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2022.113188_bib135","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3233\/JAD-180923","article-title":"Small molecule amyloid-\u03b2 protein precursor processing modulators lower amyloid-\u03b2 peptide levels via cKit signaling","volume":"67","author":"Chen","year":"2019","journal-title":"J. Alzheimer\u2019s. Dis.: JAD"},{"key":"10.1016\/j.biopha.2022.113188_bib136","first-page":"11","article-title":"Targeting PDGFR\u03b1-activated glioblastoma through specific inhibition of SHP-2-mediated Signaling","volume":"11","author":"Youzhou","year":"2019","journal-title":"Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113188_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202000706","article-title":"Small\u339dolecule inhibitors of Shp2 phosphatase as potential chemotherapeutic agents for glioblastoma: a minireview","volume":"16","author":"Mitra","year":"2020","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.biopha.2022.113188_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139539","article-title":"Analysis of food pairing in regional cuisines of India","volume":"10","author":"Jain","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113188_bib139","unstructured":"T. Nicholas, K. Navasona, Treatment of Rett Syndrome, 2020."},{"key":"10.1016\/j.biopha.2022.113188_bib140","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2013.5709","article-title":"Dual-specificity phosphatases as molecular targets for inhibition in human disease","author":"R\u00edos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.biopha.2022.113188_bib141","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pnpbp.2011.11.014","article-title":"The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity","volume":"33","author":"Kim","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222005777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222005777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:54:31Z","timestamp":1787597671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222005777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":141,"alternative-id":["S0753332222005777"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113188","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113188"}}